Implications of respiratory motion for the quantification of 2D MR spectroscopic imaging data in the abdomen.
暂无分享,去创建一个
[1] K M Brière,et al. Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair , 1998, NMR in biomedicine.
[2] J. Felmlee,et al. Orbital navigator echoes for motion measurements in magnetic resonance imaging , 1995, Magnetic resonance in medicine.
[3] A A Maudsley,et al. In‐plane motion correction for MR spectroscopic imaging , 1998, Magnetic resonance in medicine.
[4] J. Silverman,et al. Navigated single‐voxel proton spectroscopy of the human liver , 1998, Magnetic resonance in medicine.
[5] E. Haacke,et al. Pseudo‐gating: Elimination of periodic motion artifacts in magnetic resonance imaging without gating , 1987, Magnetic resonance in medicine.
[6] M. L. Wood,et al. MR image artifacts from periodic motion. , 1985, Medical physics.
[7] T R Brown,et al. Practical applications of chemical shift imaging , 1992, NMR in biomedicine.
[8] C J Hardy,et al. Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. , 1991, Radiology.
[9] M. L. Wood,et al. Planar‐motion correction with use of k‐space data acquired in fourier MR imaging , 1995, Journal of magnetic resonance imaging : JMRI.
[10] P A Bottomley,et al. Human cardiac high‐energy phosphate metabolite concentrations by 1D‐resolved NMR spectroscopy , 1996, Magnetic resonance in medicine.
[11] S J Riederer,et al. Compensation for effects of linear motion in MR imaging , 1989, Magnetic resonance in medicine.
[12] R M Henkelman,et al. K‐space description for MR imaging of dynamic objects , 1993, Magnetic resonance in medicine.
[13] K. Stock,et al. 1H MRS of liver and brain in a patient with AL amyloidosis. , 1997, Magnetic resonance imaging.
[14] J. Felmlee,et al. Adaptive technique for high-definition MR imaging of moving structures. , 1989, Radiology.
[15] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[16] T. Brown,et al. Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy. , 1995, Cancer research.
[17] W. Perman,et al. Spatially resolved high resolution spectroscopy by “four-dimensional” NMR , 1983 .
[18] D. Collins,et al. IN-VIVO 31P MAGNETIC RESONANCE SPECTROSCOPY FOR MONITORING TREATMENT RESPONSE IN BREAST CANCER , 1989, The Lancet.
[19] J. Pauly,et al. Feasibility study of lactate imaging of head and neck tumors , 1998, NMR in biomedicine.
[20] K. Uğurbil,et al. NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[21] A. G. Collins,et al. Respiratory ordered phase encoding (ROPE): a method for reducing respiratory motion artefacts in MR imaging. , 1985, Journal of computer assisted tomography.
[22] J Keegan,et al. MR navigator‐echo monitoring of temporal changes in diaphragm position: Implications for MR coronary angiography , 1997, Journal of magnetic resonance imaging : JMRI.
[23] H Yan,et al. Motion artifact suppression: a review of post-processing techniques. , 1992, Magnetic resonance imaging.
[24] J. Frahm,et al. Localized proton MR spectroscopy of the human kidney in vivo by means of short echo time STEAM sequences , 1994, Magnetic resonance in medicine.
[25] R. Alfidi,et al. The effect of motion on two-dimensional Fourier transformation magnetic resonance images. , 1984, Radiology.
[26] S. Neubauer,et al. Clinical cardiac magnetic resonance spectroscopy— present state and future directions , 1998 .
[27] D Atkinson,et al. Automatic compensation of motion artifacts in MRI , 1999, Magnetic resonance in medicine.
[28] David Atkinson,et al. Automatic correction of motion artifacts in magnetic resonance images using an entropy focus criterion , 1997, IEEE Transactions on Medical Imaging.
[29] G. Bydder,et al. Some considerations concerning susceptibility, longitudinal relaxation time constants and motion artifacts in In vivo human spectroscopy , 1989, NMR in biomedicine.
[30] R. Lenkinski,et al. Human breast lesions: characterization with proton MR spectroscopy. , 1998, Radiology.
[31] T. Brown,et al. Molar Quantitation of Hepatic Metabolites In Vivo in Proton‐decoupled, Nuclear Overhauser Effect Enhanced 31P NMR Spectra Localized by Three‐dimensional Chemical Shift Imaging , 1996, NMR in biomedicine.
[32] M. van der Graaf,et al. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. , 1997, Anticancer research.
[33] T. Powles,et al. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment , 1998, NMR in biomedicine.
[34] T. Brown,et al. Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B1 inhomogeneity , 1998, Magnetic resonance in medicine.